BFSG »

Keros Therapeutics shares owned by BFSG

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by BFSG

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.0k 200 39.76

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard World Energy Etf (VDE)
Ishares Gold Tr Ishares New (IAU)
Church & Dwight (CHD)
CSX Corporation (CSX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Raytheon Technologies Corp (RTX)
Exxon Mobil Corporation (XOM)
Costco Wholesale Corporation (COST)

View all positions for BFSG

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics